− Enrollment Completed in Phase 3 INVIGORATE Trial, with Top-Line Results Expected in the First Half of 2021 − Top-Line Results from Phase 3 TRANQUILITY
− Enrollment Completed in Phase 3 INVIGORATE Trial, with Top-Line Results Expected in the First Half of 2021 − Top-Line Results from Phase 3 TRANQUILITY